KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares Repurchased
Ratios

Vertex Pharmaceuticals (VRTX) Shares Repurchased (2018 - 2025)

Vertex Pharmaceuticals has reported Shares Repurchased over the past 7 years, most recently at $128.4 million for Q4 2025.

  • Quarterly results put Shares Repurchased at $128.4 million for Q4 2025, down 69.27% from a year ago — trailing twelve months through Dec 2025 was $2.0 billion (up 71.39% YoY), and the annual figure for FY2025 was $2.0 billion, up 71.39%.
  • Shares Repurchased for Q4 2025 was $128.4 million at Vertex Pharmaceuticals, down from $1.1 billion in the prior quarter.
  • Over the last five years, Shares Repurchased for VRTX hit a ceiling of $1.1 billion in Q3 2025 and a floor of $28.3 million in Q2 2023.
  • Median Shares Repurchased over the past 4 years was $320.3 million (2024), compared with a mean of $336.5 million.
  • Biggest five-year swings in Shares Repurchased: skyrocketed 1031.8% in 2024 and later plummeted 69.27% in 2025.
  • Vertex Pharmaceuticals' Shares Repurchased stood at $368.2 million in 2021, then plummeted by 59.4% to $149.5 million in 2023, then skyrocketed by 179.53% to $417.9 million in 2024, then plummeted by 69.27% to $128.4 million in 2025.
  • The last three reported values for Shares Repurchased were $128.4 million (Q4 2025), $1.1 billion (Q3 2025), and $391.8 million (Q2 2025) per Business Quant data.